Bremelanotide (PT-141): Libido, Arousal, and the Brain — How It Actually Works

Bremelanotide — known as PT-141 — is FDA-approved and unique among compounds used for sexual dysfunction because it acts centrally, through the brain's melanocortin receptors, rather than on the vascular system. It addresses the neurological components of arousal, not just the physical.

By UAE Peptide Clinic Research Desk

Bremelanotide — known by its research designation PT-141 — is a synthetic analogue of the melanocortin-stimulating hormone alpha-MSH. Unlike most compounds used for sexual dysfunction, it does not act on the vascular system. It acts centrally, through the brain's melanocortin receptors, which means it addresses the neurological and motivational components of sexual arousal rather than simply the haemodynamic ones.

Mechanism of Action

PT-141 is an agonist of the melanocortin 4 receptor (MC4R) in the central nervous system. MC4R is expressed in brain regions involved in sexual motivation, including the hypothalamus. Activation of this receptor pathway increases sexual desire and arousal in both men and women by modulating the neurobiological signals that drive libido. This central mechanism is why PT-141 is effective in cases where the cause of low libido is neurological or psychological rather than primarily physical.

Clinical Evidence and Applications

PT-141 is FDA-approved as Vyleesi for hypoactive sexual desire disorder in premenopausal women. In physician-supervised protocols, it is used for libido support in both sexes, particularly in cases where hormonal optimisation alone has not fully restored desire, or where anxiety, stress, or medication side effects have suppressed the neurological drive to arousal.

• Available formats: Vial, Pen, Nasal Spray
• FDA-approved (Vyleesi) for HSDD in premenopausal women
• Acts centrally on MC4R — neurological rather than vascular mechanism
• Effective in both male and female libido dysfunction

PT-141 is available through UAE Peptide Clinic under physician supervision. A full hormone panel and health history review will inform whether it is the appropriate approach for your situation. Explore the protocol at /peptides/pt-141 or book a consultation at /book.